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The last couple of years a large numberof innovativesurgical
techniques to correct genital prolapse and/or stress inconti-
nence have been introduced. As a result uro-gynaecologists
are confronted with a new dilemma: Should they start using
these promising new surgical techniques, or should they
await the results from randomized controlled trials (RCT)
with long-term follow-up before doing so?
It is no surprise that, together with the introduction of new
surgical techniques, the use of registries for the evaluation of
their outcome have gained in popularity. These registries
provide a tool to gather information on short notice:
Registries are easily accessible for physicians, do not need
informed consent from the patient, do not demand for any
additional investigations, and allow for data registration at
any time that is comfortable for the doctor. Furthermore, it
has been argued that, in contrast to other sources, the results
from registries are more readily generalizable as the data do
not depend on selection of patients or doctors but are derived
from dailyclinicalpractice.Theadvantageover a RCTdueto
larger sample sizes is that registries can provide information
about rare events and complications.
However, there are important risks in the interpretation
of data generated by registries.
Firstly, registries are subject to confounders. Without the
accurate identification and measurement of confounders, it
may be difficult to estimate the true relationship between
exposure(s) and outcome(s) of interest. An important
confounder concerns the patient characteristics included in
theregistry, asthere is no control on whois included andwho
is not. Patients with low complication risks who underwent a
straightforward procedure may be overrepresented. Whenev-
erseverecomplicationsoccur,theattendingphysicianmaybe
too busy with solving these problems and may simply forget
to register this complicated case, or the opposite may happen
whenever the physician feels that it is especially important to
register cases with adverse outcomes based on the motivation
to share these experiences with colleagues.
Secondly, there is no control on the quality of the data
collection. Mostly, financial support to allow high-quality
data collection has not been provided. As a result the
reliability of documentation, e.g., amount of blood loss,
estimated surgery time, pelvic organ prolapse quantification
(POP-Q) score after surgery, mainly depends on the motiva-
tion of the physician and his/her team. Furthermore, the
qualityofdatacollectionmaybehamperedbytheselectionof
subjective outcome measures, e.g., when physicians are
asked to score the encountered difficulties in performing the
procedure on a 7-point Likert scale.
Thirdly, many registries have been initiated by medical
companies producing surgical meshes or devices. By defini-
tion, business interests are involved in these databases. As a
result,theprimaryoutcomeintheseregistriesisnotnecessarily
theone withthe highestclinicalrelevance.Itisimaginablethat
theindustry sponsoringtheseregistrieshasa goal to document
a favorable outcome of their products. Furthermore, many
clinical relevant outcome measures (e.g., patient satisfaction,
treatmentadherence,costs)are,inmostcases,notincludedina
registry, as these are quite difficult to obtain.
As a consequence of the limitations of registries, it is
difficult to compare the obtained results to those of pro-
spective comparative studies. Therefore, the problem with
registries is that wrong conclusions may be drawn with
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Because of the business interests involved, the absence of
prospective data entry, the judgement of clinical outcomes
by directly involved physicians, and the lack of a proper
control group undergoing standard treatment, the reliability
of registries as data sources should be judged with utmost
care. From a scientific viewpoint, therefore, registries cannot
possibly compare with data provided by randomized trials,
and physicians motivated to contribute to studies hopefully
decide to participate in multi-center comparative studies
rather than in registries.
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